Ford's $13 Mil. Annual Prilosec Spend Partly Due To DTC Ads, Exec Says
Executive Summary
Over-prescribing of AstraZeneca's proton pump inhibitor Prilosec to Ford Motor Company health beneficiaries can be partly attributed to direct-to-consumer advertising, Ford Motor Company Health Care Management Director Woodrow Myers, MD, maintained at a health care conference sponsored by the Wall Street Journal May 5 in Washington, D.C.